Denteric is developing a vaccine based on research conducted at the University of Melbourne.
Denteric's investors include Brandon Capital, University of Melbourne, CSL, Medical Research Commercialisation Fund (MRCF), United News of India.
Denteric is headquartered in Melbourne, Australia.
Denteric is developing a vaccine based on research conducted at the University of Melbourne.
Denteric is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Denteric — Funding & Investors." VCBacked, July 20, 2022, https://www.vcbacked.co/company/denteric. Accessed September 30, 2026.
VCBacked. (2022). Denteric — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/denteric
{{cite web |title=Denteric — Funding & Investors |url=https://www.vcbacked.co/company/denteric |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated